IL33 and chronic kidney disease: This could explain why IL-33, which modestly increases Tregs, depends on type 2–mediated eosinophil expansion in CKD (99), but IL233, which expands both ILC2s and Tregs, does significantly upregulate type 2 responses in IRI (100).